As of 2026-09-13, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (20.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.49 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -292.9%.
The range of the Relative Valuation is (16.74) - (27.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 27.1x | 14.0x |
| Forward P/E multiples | 12.1x - 20.1x | 15.4x |
| Fair Price | (16.74) - (27.70) | (20.24) |
| Upside | -259.6% - -364.1% | -292.9% |
| Date | P/E |
| 2026-09-04 | -7.73 |
| 2026-09-03 | -7.73 |
| 2026-09-02 | -7.92 |
| 2026-09-01 | -7.68 |
| 2026-08-31 | -7.62 |
| 2026-08-28 | -7.53 |
| 2026-08-27 | -7.86 |
| 2026-08-26 | -7.82 |
| 2026-08-25 | -7.90 |
| 2026-08-24 | -7.83 |
| 2026-08-21 | -8.05 |
| 2026-08-20 | -8.06 |
| 2026-08-19 | -8.52 |
| 2026-08-18 | -8.00 |
| 2026-08-17 | -7.74 |
| 2026-08-14 | -7.29 |
| 2026-08-13 | -7.34 |
| 2026-08-12 | -7.43 |
| 2026-08-11 | -7.09 |
| 2026-08-10 | -6.71 |
| 2026-08-07 | -6.68 |
| 2026-08-06 | -6.35 |
| 2026-08-05 | -6.17 |
| 2026-08-04 | -6.24 |
| 2026-08-03 | -6.10 |
| 2026-07-31 | -5.93 |
| 2026-07-30 | -6.15 |
| 2026-07-29 | -6.07 |
| 2026-07-28 | -6.14 |
| 2026-07-27 | -6.28 |
| 2026-07-24 | -6.18 |
| 2026-07-23 | -6.26 |
| 2026-07-22 | -6.24 |
| 2026-07-21 | -6.49 |
| 2026-07-20 | -6.33 |
| 2026-07-17 | -6.52 |
| 2026-07-16 | -6.66 |
| 2026-07-15 | -7.23 |
| 2026-07-14 | -7.05 |
| 2026-07-13 | -7.18 |
| 2026-07-10 | -7.41 |
| 2026-07-09 | -7.66 |
| 2026-07-08 | -7.46 |
| 2026-07-07 | -7.50 |
| 2026-07-06 | -7.02 |
| 2026-07-02 | -7.00 |
| 2026-07-01 | -6.88 |
| 2026-06-30 | -7.13 |
| 2026-06-29 | -7.19 |
| 2026-06-26 | -7.15 |